March Forth Philadelphia
A comprehensive plan to save lives
March Forth offers a four-pronged strategy to drive screening rates in the Philadelphia community above 80%.
Implementing this massive outreach campaign, aimed at patients, physicians, and the systems they navigate, will result in upwards of an additional 100,000 individuals screened annually, saving hundreds of lives.
Did you know that colorectal cancer is the second-leading cause of cancer deaths in the United States?
An astounding 50,000 Americans die each year from colorectal cancer, and the number is growing rapidly for those under the age of 50. The tragic thing is that most of these deaths could have—and should have—been prevented. Do you want to be part of saving 250 lives in Philadelphia from colorectal cancer?
March Forth has been created to ensure 100% focus on our goal of saving 100,000 American lives.
Starting in Philadelphia, we are mounting a national effort to attack colorectal cancer by driving up screening rates.
We are building national capacity to replicate this model across the country.
A widespread colorectal cancer screening campaign is a unique opportunity to save lives on a massive scale, using already existing and proven technologies.
Population navigation
Employ multitouch outreach to ensure patients are current on screenings
Vulnerable community outreach
Conduct outbound navigation for vulnerable populations and support the cost of screening and follow-up care
Marketing campaign to drive awareness
Multimedia campaigns for patients and physicians to highlight the importance of screening, testing options, and to emphasize there is no “best” test
Health system education
Educate physicians and health systems on colorectal cancer screening options and ensure dissemination of current screening information and patient education during and after the appointment
Why Philadelphia, why now?
Philadelphia’s large population of at-risk individuals are drastically under-screened for colorectal cancer in comparison with other major cities. This combined with world-class healthcare institutions and the presence of our many supporters and advocates in the community make Philadelphia the ideal choice for our pilot program.
Working with partners, families, and advocates across the city, March Forth will mobilize Philadelphians to eradicate colorectal cancer in our community. We will do this by increasing the city’s tragically low screening rates through a cohesive and wide-ranging set of initiatives aimed at outreach, education, and awareness. Today, we must help individuals overcome barriers, improve access, and increase the quality of screenings.
Philadelphia Colorectal Cancer Screening Facts
420,000
Philadelphia population between ages of 50-84
230,000
Total unscreened population in Philadelphia
44%
Philadelphia has a remarkably low screening rate for colorectal cancer compared to the national average of 67%
26%
of Philadelphians live below the poverty line
700
700 people in Philadelphia diagnosed with colorectal cancer annually
Interventions to save lives
$5 million
Investment over two years
100K-200K
Additional Philadelphia screenings
300 additional lives saves
and thousands can avoid needless suffering
How?
Colorectal cancer is needlessly claiming Philadelphian lives each year. The wonderful thing is that we know what we need to change this. With support from our partners, families and friends, we are well on our way to making a significant difference in Philadelphia and across our country.
Founding members
John Backus
Managing Partner, Proof VC
John M. Daly, MD, FACS
Harry C. Donahoo Professor, Surgery, Lewis Katz School of Medicine at Temple University
Surgical Director, William Maul Measey Institute for Clinical Simulation and Patient Safety
Emeritus Dean, Lewis Katz School of Medicine at Temple University
Attending Surgeon, Fox Chase Cancer Center
Lee Dranikoff
Managing Director, American Securities
Joseph A. Frick
Senior Advisor at Diversified Search, prior CEO of Independence Blue Cross
Kevin T. Lewis
Principal, PWC
David Schoeman
Senior Partner, McKinsey & Company
SPONSORS
